Gleason Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,217
| Closed | -$443K | – | 226 |
|
|
2023
Q3 | $443K | Buy |
12,217
+123
| +1% | +$4.46K | 0.12% | 49 |
|
|
2023
Q2 | $431K | Buy |
12,094
+106
| +0.9% | +$3.78K | 0.11% | 53 |
|
|
2023
Q1 | $427K | Buy |
11,988
+110
| +0.9% | +$3.91K | 0.12% | 52 |
|
|
2022
Q4 | $417K | Buy |
11,878
+140
| +1% | +$4.92K | 0.13% | 53 |
|
|
2022
Q3 | $345K | Buy |
11,738
+90
| +0.8% | +$2.65K | 0.12% | 48 |
|
|
2022
Q2 | $634K | Buy |
11,648
+148
| +1% | +$8.06K | 0.22% | 39 |
|
|
2022
Q1 | $626K | Buy |
11,500
+127
| +1% | +$6.91K | 0.19% | 40 |
|
|
2021
Q4 | $627K | Buy |
11,373
+147
| +1% | +$8.1K | 0.2% | 42 |
|
|
2021
Q3 | $536K | Buy |
11,226
+144
| +1% | +$6.88K | 0.19% | 47 |
|
|
2021
Q2 | $552K | Buy |
11,082
+188
| +2% | +$9.36K | 0.2% | 44 |
|
|
2021
Q1 | $486K | Buy |
10,894
+1,327
| +14% | +$59.2K | 0.19% | 45 |
|
|
2020
Q4 | $440K | Buy |
9,567
+121
| +1% | +$5.57K | 0.21% | 45 |
|
|
2020
Q3 | $444K | Buy |
9,446
+109
| +1% | +$5.12K | 0.26% | 44 |
|
|
2020
Q2 | $476K | Buy |
9,337
+133
| +1% | +$6.78K | 0.29% | 38 |
|
|
2020
Q1 | $436K | Buy |
9,204
+96
| +1% | +$4.55K | 0.35% | 35 |
|
|
2019
Q4 | $535K | Buy |
+9,108
| New | +$535K | 0.32% | 39 |
|